TinyGemsBreaks Archive - Page 8 of 126

ThursdayApr 03, 2025 9:30 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Highlights U.S. Assembly and Tariff Exempt Status for EV Lineup

Mullen Automotive (NASDAQ: MULN) announced that its Mullen and Bollinger commercial electric vehicles are fully assembled in the United States and exempt from recently announced tariffs on vehicles and components. With 67% and 71% of components sourced domestically for Mullen and Bollinger respectively, the company emphasizes its commitment to U.S. manufacturing and supply chain stability. Mullen’s lineup includes the Mullen ONE and Mullen THREE, while Bollinger offers the B4 chassis cab, which began deliveries in October 2024. To view the full press release, visit https://ibn.fm/KnGDK About Mullen Automotive Inc. Mullen Automotive is a Southern California-based automotive company building the next…

TuesdayApr 01, 2025 11:09 am

TinyGemsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Acquires Skytech to Expand AI Robotics in Hospitality Sector

Nightfood Holdings (OTCQB: NGTF), an innovator in hospitality automation, has acquired Skytech Automated Solutions, Inc., a leader in AI-driven service technologies for hotels. This strategic move follows Nightfood’s recent acquisition of Carryout Supplies and enhances its Robotics-as-a-Service (RaaS) offerings. Skytech’s Laundry Helper robot, already in use at multiple hotel properties, will now be integrated into Nightfood’s broader automation platform to improve operational efficiency and guest experience. The combined capabilities are expected to boost market reach, recurring revenue, and operational scalability. To view the full press release, visit https://ibn.fm/Mtbgi About Nightfood Holdings Inc. Nightfood is a forward-thinking holding company dedicated to…

TuesdayApr 01, 2025 10:00 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances TPI 287 for GBM, Ends 2024 with Strong Cash Position

CNS Pharmaceuticals (NASDAQ: CNSP) a biopharmaceutical company targeting brain and CNS cancers, reported a full-year 2024 net loss of $14.9 million, down from $18.9 million in 2023, due to reduced R&D spending. Despite Berubicin missing its primary endpoint in a glioblastoma multiforme (GBM) trial, the drug demonstrated safety and comparable efficacy, guiding future analysis. The company is shifting focus to TPI 287, a candidate with orphan drug designation and prior clinical data. With $6.5 million in cash at year-end and an additional $9.9 million raised post-period, CNS expects funding to last through Q1 2026. To view the full press release,…

TuesdayApr 01, 2025 9:40 am

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $3.9 Million Offering to Advance Immunotherapy Programs

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted immunotherapies, closed its previously announced registered direct offering and concurrent private placement with a single institutional investor, raising approximately $3.9 million in gross proceeds. The offering included 3,325,000 shares of common stock and pre-funded warrants for 2,728,000 shares, along with Series G warrants for 6,053,000 shares. Proceeds will support working capital and advance Calidi’s clinical and preclinical cancer therapy programs. To view the full press release, visit: https://ibn.fm/wgwu3 About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s novel stem…

MondayMar 31, 2025 10:30 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Defeats Motion to Dismiss in Spoofing Lawsuit

Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, announced a key legal victory after a federal court denied a motion to dismiss its spoofing lawsuit against IMC Financial Markets, Clear Street Markets LLC, UBS Securities LLC, and others. The lawsuit alleges that defendants used high-frequency algorithmic trading tactics—including “Baiting Orders”—to manipulate Mullen’s stock price between Nov. 2021 and Nov. 2023. The court found sufficient evidence that defendants placed and canceled large volumes of sell orders to artificially depress prices, harming Mullen and its shareholders. The case will now proceed to discovery. To view the full press release, visit https://ibn.fm/Zz4rf About…

FridayMar 28, 2025 3:40 pm

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Develop 7.2 MW Hoadley Hill Rd Solar Project

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has announced plans to develop a 7.2 MW DC ground-mount solar power project known as the Hoadley Hill Rd project (the “Project”) on a site located in upstate New York. According to the announcement, the Project is another key addition to SolarBank's expanding development pipeline—which exceeds one gigawatt—as well as the company's commitment to advancing community solar. Assuming receipt of the requested interconnection approval, SolarBank will continue efforts to complete the permitting process and secure necessary financing for construction of the Project. The Project is expected…

FridayMar 21, 2025 2:35 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI): Poised in the Future of Oncology with Cutting-Edge Treatments

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company at the forefront of research and development of innovative treatments in the field of immuno-oncology. With cancer being the second leading cause of death globally, the company focuses on harnessing antitumor virotherapies and patented technologies designed to protect and potentiate the virotherapy during administration to combat cancer more effectively and with fewer side effects. The company’s approach includes a systemic platform using extracellular enveloped viruses and an intratumoral platform utilizing stem cells to protect the therapy from the body’s immune system during administration. Calidi’s pipeline includes promising therapies such as RTNova,…

ThursdayMar 20, 2025 9:59 am

TinyGemsBreaks – Bell2Bell Podcast Features Walk-in Dermatology CEO Steven Dresner

Walk-in Dermatology is transforming patient access to dermatological care by combining the convenience of urgent care with the expertise of traditional dermatology. In the latest Bell2Bell podcast, Steven Dresner, CEO of Walk-in Dermatology, discusses the company’s mission to provide same-day, high-quality dermatology services without the long wait times typical of traditional practices. Dresner explains how the model serves patients who need immediate care for conditions like rashes or acne but face delays in scheduling with conventional dermatologists. Join IBN’s Carmel Fisher and Dresner as they examine Walk-in Dermatology’s business model, including patient acquisition costs and visit frequency, and how it…

WednesdayMar 19, 2025 11:02 am

TinyGemsBreaks – Authentic Holdings (OTC: AHRO) to Acquire Goliath Motion Pictures for $11 Million

Authentic Holdings (OTC: AHRO) announced its agreement to acquire Goliath Motion Pictures Entertainment in an $11 million equity-based transaction. The acquisition will bring over 40,000 titles, including award-winning shows and films such as In Living Color, The Cosby Show, and Open Range, under Authentic Holdings' ownership. The deal is structured as Convertible Preferred Stock, with conversion restrictions for three years to minimize shareholder dilution. Management expects the acquisition to strengthen Maybacks Global Entertainment’s market position, increase advertising revenue, and support expansion into all major U.S. markets. An 8-K will be filed with the SEC upon completion. To view the full…

TuesdayMar 18, 2025 10:09 am

TinyGemsBreaks – Brera Holdings PLC (NASDAQ: BREA) Sponsors ‘Pepito Day’ Honoring Giuseppe Rossi’s Football Legacy

Brera Holdings (NASDAQ: BREA), an international multi-club ownership company, has announced its sponsorship of “Pepito Day,” a tribute event celebrating the career of Giuseppe “Pepito” Rossi. Set for March 22, 2025, at Stadio Artemio Franchi in Florence, Italy, the event will bring together legendary football figures, including Sir Alex Ferguson, Gabriel Batistuta, Andrea Pirlo, and Giorgio Chiellini. Rossi, a Brera Holdings advisory board member, played a key role in Fiorentina’s history and continues to contribute to the company’s global football operations. The celebration will feature a youth tournament, meet-and-greet sessions, and a star-studded match. To view the full press release,…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks